Drugmakers including Eli Lilly, CSL Behring, and Novo Nordisk, are among the list of companies with warning letters from the FDA's Center for Drug Evaluation and Research (CDER) in the latest drop, although, the bulk of them have been sent to online pharmacies and compounding pharmacies, many of them promoting GLP-1 agonist-based drugs for weight loss
Without enough protein and a training stimulus, the body breaks down muscle tissue faster than it builds it
Common positive reports Reduced appetite and cravings, particularly for sugar and processed foods Improved digestive regularity (likely from fiber components) Modest weight loss (typically 5-15 pounds over several months) Improved energy levels Better food choices and eating habits Common negative reports Results not comparable to pharmaceutical GLP-1 medications High price relative to perceived value Digestive discomfort during initial weeks Weight loss plateauing after initial improvements Difficulty distinguishing supplement effects from lifestyle changes made simultaneously The pattern is consistent with what the evidence predicts
B12 injections can help fight fatigue, making it easier to stay motivated and energized for workouts and daily activities
Additionally, patients taking medications with significant drug interactions or those with conditions that could be exacerbated by changes in gastric emptying or metabolic function should be carefully evaluated by their prescribing provider
Drugs and treatments Adolescent THC treatment was conducted between PND35 and PND45 (Fig